Yong-Man Kim
Direttore/Membro del Consiglio presso NKMAX CO., LTD.
Patrimonio netto: 18 812 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Yong-Man Kim
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Yong-Man Kim tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| J WAY CO., LTD. | Movies/Entertainment | Chief Executive Officer | |
Mercy Corps
 Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Services to the Health Industry | Director/Board Member | |
| The University of Chicago | College/University | Undergraduate Degree | |
| TONG YANG LIFE INSURANCE CO., LTD. | Life/Health Insurance | Chief Investment Officer | |
| University of Quebec | College/University | Undergraduate Degree | |
| Yonsei University | College/University | Corporate Officer/Principal | |
| Korea University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ATGen Canada, Inc. | Chief Executive Officer | ||
| ATGen America, Inc. | Chief Executive Officer | ||
Atgen H&D
 Atgen H&D Pharmaceuticals: OtherHealth Technology Atgen H&D develops protein products. Sang-Woo Park has been the CEO of the South Korean company since 2016. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
| George Washington University School of Medicine & Health | College/University | Doctorate Degree | |
PeproMene Bio, Inc.
 PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Pharmaceuticals: Major | Chief Executive Officer | |
coAsia Biotech Corp.
 coAsia Biotech Corp. BiotechnologyHealth Technology Part of NKMAX Co., Ltd. (South Korea), coAsia Biotech Corp. manufactures biological products. Sang-Woo Park has been the CEO of the Thai company since 2016. coAsia Biotech was acquired by NKMAX Co., Ltd. (South Korea) on February 28, 2018 for $0.10 million. | Biotechnology | Chief Executive Officer | |
| Nkmax H&D Co. Ltd. | Chief Executive Officer | ||
| Atgen Japan | Chief Executive Officer | ||
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| Nkmax Japan, Inc. | Chief Executive Officer | ||
Fuse Biotherapeutics, Inc.
 Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Biotechnology | Founder | |
| Gideons Promise, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
| Corea del Sud | 8 |
| Stati Uniti | 8 |
| Canada | 3 |
| Giappone | 3 |
| Regno Unito | 2 |
Settori
| Consumer Services | 7 |
| Health Technology | 7 |
| Health Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 14 |
| Chief Executive Officer | 14 |
| Chairman | 12 |
| Founder | 5 |
| Undergraduate Degree | 5 |
Contatti più connessi
| Insiders | |
|---|---|
| Sang-Woo Park | 13 |
| Paul Y. Song | 9 |
| Yong-Hwan Cho | 3 |
| Jun-Yong Song | 3 |
| Kang-Yong Pierre | 2 |
| Jeong-Heon Cha | 2 |
| Jeong-Chan Lee | 1 |
- Borsa valori
- Insiders
- Yong-Man Kim
- Connessioni Società
